Informations

Oncology Frontier – UroStream: What do you consider to be the most important recent innovations in UC research in China, particularly in the field of antibody–drug conjugates (ADCs)? Professor Zhisong…

Oncology Frontier: For advanced urothelial carcinoma, platinum-based chemotherapy remains the standard first-line treatment in the current CSCO guidelines. With the release of results from studies like EV-302, how do you…

Healthy China, Urology First Chinese Urologists Drive Innovation and Excellence Oncology Frontier – UroStream: Professor Xing, what do you see as the most significant developments in China’s urology field over…

The 2025 Annual Meeting of the Chinese Urological Association (CUDA) was held from June 12–15 in the romantic city of Zhuhai. With the theme “Healthy China, Urology in Action,” the conference brought together experts from across the country to share the latest insights and practical experience in urologic surgery. At the conference, Professor Xuepei Zhang…

The 2025 Annual Meeting of the Chinese Urological Doctors Association (CUDA) was successfully held from June 12 to 15 in the romantic city of Zhuhai. With the theme “Healthy China, Urology in Action,” the conference gathered urological professionals from across the country to share cutting-edge knowledge and practical experience in the field. Professor Linhui Wang…